Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Altimmune (ALT) Profit After Tax: 2010-2024

Historic Profit After Tax for Altimmune (ALT) over the last 15 years, with Dec 2024 value amounting to -$95.1 million.

  • Altimmune's Profit After Tax rose 16.77% to -$19.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$83.9 million, marking a year-over-year increase of 18.94%. This contributed to the annual value of -$95.1 million for FY2024, which is 7.48% down from last year.
  • Per Altimmune's latest filing, its Profit After Tax stood at -$95.1 million for FY2024, which was down 7.48% from -$88.4 million recorded in FY2023.
  • Altimmune's Profit After Tax's 5-year high stood at -$49.0 million during FY2020, with a 5-year trough of -$97.1 million in FY2021.
  • Moreover, its 3-year median value for Profit After Tax was -$88.4 million (2023), whereas its average is -$89.4 million.
  • Per our database at Business Quant, Altimmune's Profit After Tax crashed by 139.01% in 2020 and then increased by 12.75% in 2022.
  • Over the past 5 years, Altimmune's Profit After Tax (Yearly) stood at -$49.0 million in 2020, then tumbled by 97.96% to -$97.1 million in 2021, then rose by 12.75% to -$84.7 million in 2022, then decreased by 4.41% to -$88.4 million in 2023, then decreased by 7.48% to -$95.1 million in 2024.